The different regulatory effects of p53 status on multidrug resistance are determined by autophagy in ovarian cancer cells

Biomedicine and Pharmacotherapy

Volumn 66, Issue 4, 2012, Pages 271-278

  Kong, Dejuan ^a   Ma, Shumei ^a   Liang, Bing ^a   Yi, Heqing ^a   Zhao, Yinlong ^b   Xin, Rui ^b   Cui, Li ^c   Jia, Lili ^a   Liu, Xin ^d   Liu, Xiaodong ^a,e  

^a Center for Radiological Research   (China)

^b THE SECOND HOSPITAL OF JILIN UNIVERSITY   (China)

^c Changchun Central Hospital   (China)

^d JILIN UNIVERSITY   (China)

^e CHINA JAPAN UNION HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

175H; Autophagy; Multidrug resistance; Ovarian cancer; P53

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CISPLATIN; DANSYLCADAVERINE; ETOPOSIDE; HOE 33342; PIRARUBICIN; PROPIDIUM IODIDE; PROTEIN P53; VINCRISTINE;

APOPTOSIS; ARTICLE; AUTOPHAGY; CARCINOMA CELL; CONTROLLED STUDY; DRUG SENSITIVITY; FEMALE; GENETIC ENGINEERING; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; OVARY CARCINOMA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; AUTOPHAGY; CELL LINE, TUMOR; DRUG RESISTANCE, MULTIPLE; FEMALE; HUMANS; MUTATION; OVARIAN NEOPLASMS; P-GLYCOPROTEIN; POLYMERASE CHAIN REACTION; PROTEIN ENGINEERING; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84862494695     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2011.12.002     Document Type: Article

References (35)

1. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55:74-108.
2. Bhoola S., Hoskins W.J. Diagnosis and management of epithelial ovarian cancer. Obstet Gynecol 2006, 107:1399-1410.
3. Yague E., Arance A., Kubitza L., O'Hare M., Jat P., Ogilvie C.M., et al. Ability to acquire drug resistance arises early during the tumorigenesis process. Cancer Res 2007, 67:1130-1137.
4. Tsuruo T., Naito M., Tomida A., Fujita N., Mashima T., Sakamoto H., et al. Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal. Cancer Sci 2003, 94:15-21.
5. Szakacs G., Paterson J.K., Ludwig J.A., Booth-Genthe C., Gottesman M.M. Targeting multidrug resistance in cancer. Nat Rev Drug Discov 2006, 5:219-234.
6. Lu L., Katsaros D., Wiley A., Rigault de la Longrais I.A., Puopolo M., Yu H. Expression of MDR1 in epithelial ovarian cancer and its association with disease progression. Oncol Res 2007, 16:395-403.
7. Townsend D.M., Shen H., Staros A.L., Gate L., Tew K.D. Efficacy of a glutathione-S-transferase pi-activated prodrug in platinum-resistant ovarian cancer cells. Mol Cancer Ther 2002, 1:1089-1095.
8. Stevens J.B., Liu G., Bremer S.W., Ye K.J., Xu W., Xu J., et al. Mitotic cell death by chromosome fragmentation. Cancer Res 2007, 67:7686-7694.
9. Kroemer G., El-Deiry W.S., Golstein P., Peter M.E., Vaux D., Vandenabeele P., et al. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death. Cell Death Differ 2005, 12(Suppl. 2):1463-1467.
10. Castedo M., Perfettini J.L., Roumier T., Andreau K., Medema R., Kroemer G. Cell death by mitotic catastrophe: a molecular definition. Oncogene 2004, 23:2825-2837.
11. Semenza G.L. Mitochondrial autophagy: life and breath of the cell. Autophagy 2008, 4:534-536.
12. Shintani T., Klionsky D.J. Autophagy in health and disease: a double-edged sword. Science 2004, 306:990-995.
13. Ito H., Daido S., Kanzawa T., Kondo S., Kondo Y. Radiation-induced autophagy is associated with LC3 and its inhibition sensitizes malignant glioma cells. Int J Oncol 2005, 26:1401-1410.
14. Paglin S., Hollister T., Delohery T., Hackett N., McMahill M., Sphicas E., et al. A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles. Cancer Res 2001, 61:439-444.
15. Gozuacik D., Kimchi A. Autophagy as a cell death and tumor suppressor mechanism. Oncogene 2004, 23:2891-2906.
16. Cao C., Subhawong T., Albert J.M., Kim K.W., Geng L., Sekhar K.R., et al. Inhibition of mammalian target of rapamycin or apoptotic pathway induces autophagy and radiosensitizes PTEN null prostate cancer cells. Cancer Res 2006, 66:10040-10047.
17. Jin S., White E. Tumor suppression by autophagy through the management of metabolic stress. Autophagy 2008, 4:563-566.
18. Zhang C.C., Yang J.M., White E., Murphy M., Levine A., Hait W.N. The role of MAP4 expression in the sensitivity to paclitaxel and resistance to vinca alkaloids in p53 mutant cells. Oncogene 1998, 16:1617-1624.
19. Xue C., Haber M., Flemming C., Marshall G.M., Lock R.B., MacKenzie K.L., et al. p53 determines multidrug sensitivity of childhood neuroblastoma. Cancer Res 2007, 67:10351-10360.
20. Gottesman M.M., Ling V. The molecular basis of multidrug resistance in cancer: the early years of P-glycoprotein research. FEBS Lett 2006, 580:998-1009.
21. Tanaka T., Umesaki N. Radiation reduces pirarubicin sensitivity in human cervical squamous cell carcinoma cells. Oncol Rep 2005, 13:1165-1168.
22. Charoentum C., Thongprasert S., Chewaskulyong B., Munprakan S. Experience with gemcitabine and cisplatin in the therapy of inoperable and metastatic cholangiocarcinoma. World J Gastroenterol 2007, 13:2852-2854.
23. Vousden K.H., Prives C. Blinded by the light: the growing complexity of p53. Cell 2009, 137:413-431.
24. Berns E.M., Foekens J.A., Vossen R., Look M.P., Devilee P., Henzen-Logmans S.C., et al. Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer. Cancer Res 2000, 60:2155-2162.
25. Reles A., Wen W.H., Schmider A., Gee C., Runnebaum I.B., Kilian U., et al. Correlation of p53 mutations with resistance to platinum-based chemotherapy and shortened survival in ovarian cancer. Clin Cancer Res 2001, 7:2984-2997.
26. Goh A.M., Coffill C.R., Lane D.P. The role of mutant p53 in human cancer. J Pathol 2011, 223:116-126.
27. Gai X.D., Li G.L., Huang J.Z., Xue H.J., Wang D. Reversal of multidrug resistance of human hepatocellular carcinoma cells by wild-type p53 gene and related mechanisms. Ai Zheng 2006, 25:954-959.
28. Okaichi K., Wang L.H., Sasaki J., Saya H., Tada M., Okumura Y. A point mutation of human p53, which was not detected as a mutation by a yeast functional assay, led to apoptosis but not p21Waf1/Cip1/Sdi1 expression in response to ionizing radiation in a human osteosarcoma cell line, Saos-2. Int J Radiat Oncol Biol Phys 1999, 45:975-980.
29. Peng Y., Chen L., Li C., Lu W., Agrawal S., Chen J. Stabilization of the MDM2 oncoprotein by mutant p53. J Biol Chem 2001, 276:6874-6878.
30. Trepel M., Groscurth P., Malipiero U., Gulbins E., Dichgans J., Weller M. Chemosensitivity of human malignant glioma: modulation by p53 gene transfer. J Neurooncol 1998, 39:19-32.
31. Liu X.W., Su Y., Zhu H., Cao J., Ding W.J., Zhao Y.C., et al. HIF-1α-dependent autophagy protects HeLa cells from fenretinide (4-HPR)-induced apoptosis in hypoxia. Pharmacol Res 2010, 62:416-425.
32. Scherz-Shouval R., Weidberg H., Gonen C., Wilder S., Elazar Z., Oren M. p53-dependent regulation of autophagy protein LC3 supports cancer cell survival under prolonged starvation. Proc Natl Acad Sci U S A 2010, 107:18511-18516.
33. Mosner J., Mummenbrauer T., Bauer C., Sczakiel G., Grosse F., Deppert W. Negative feedback regulation of wild-type p53 biosynthesis. EMBO J 1995, 14:4442-4449.
34. Polyak K., Waldman T., He T.C., Kinzler K.W., Vogelstein B. Genetic determinants of p53-induced apoptosis and growth arrest. Genes Develop 1996, 10:1945-1952.
35. Boya P., Gonzalez-Polo R.A., Casares N., Perfettini J.L., Dessen P., Larochette N., et al. Inhibition of macroautophagy triggers apoptosis. Mol Cell Biol 2005, 25:1025-1040.